FilingReader Intelligence
Shilpa Medicare's Bengaluru unit receives favorable US FDA classification
July 16, 2025 at 04:49 AM UTC•By FilingReader AI
Shilpa Medicare Limited's Unit VI in Bengaluru received a Voluntary Action Indicated classification from the US FDA following a GMP inspection conducted from October 24-30, 2024.
The facility manufactures oral dissolving films and transdermal systems, and currently supplies oral film products to the US and other markets.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:SHILPAMED•Bombay Stock Exchange
News Alerts
Get instant email alerts when Shilpa Medicare publishes news
Free account required • Unsubscribe anytime